Exploration of Lipid Metabolism in Relation with Plasma Membrane Properties of Duchenne Muscular Dystrophy Cells: Influence of L-Carnitine

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Le Borgne, Françoise ^a   Guyot, Stéphane ^b   Logerot, Morgan ^a   Beney, Laurent ^b   Gervais, Patrick ^b   Demarquoy, Jean ^a  

^a Faculté des Sciences Gabriel   (France)

^b UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARNITINE; CHOLESTEROL; DYSTROPHIN; MESSENGER RNA; MONOUNSATURATED FATTY ACID; POLYUNSATURATED FATTY ACID; VERY LONG CHAIN FATTY ACID;

ACOT2 GENE; ACSL1 GENE; ADOLESCENT; AMINO ACID DEFICIENCY; AMINO ACID METABOLISM; ANISOTROPY; ARTICLE; CASE REPORT; CELL LEVEL; CELL MEMBRANE FLUIDITY; CELL PROTECTION; CELL TRANSPORT; CONTROLLED STUDY; CPT1 GENE; CPT2 GENE; DIET SUPPLEMENTATION; DUCHENNE MUSCULAR DYSTROPHY; FATTY ACID METABOLISM; FLUORESCENCE ANALYSIS; GENE; GENETIC CODE; HUMAN; HUMAN CELL; ISOTOPE LABELING; LIPID ANALYSIS; LIPID COMPOSITION; MALE; MEMBRANE DAMAGE; MEMBRANE STRUCTURE; MITOCHONDRIAL RESPIRATION; OCTN1 GENE; OCTN2 GENE;

ADOLESCENT; CARNITINE; CELL MEMBRANE; FATTY ACIDS; HUMANS; LIPID METABOLISM; MALE; MITOCHONDRIA; MUSCLE CELLS; MUSCULAR DYSTROPHY, DUCHENNE; PHOSPHOLIPIDS;

EID: 84870278227     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049346     Document Type: Article

References (54)

1. Blake DJ, Weir A, Newey SE, Davies KE, (2002) Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol Rev 82: 291-329.
2. Ervasti JM, (2003) Costameres: the Achilles' heel of Herculean muscle. J Biol Chem 278: 13591-13594.
3. Deconinck N, Dan B, (2007) Pathophysiology of duchenne muscular dystrophy: current hypotheses. Pediatr Neurol 36: 1-7.
4. Mouly V, Aamiri A, Perie S, Mamchaoui K, Barani A, et al. (2005) Myoblast transfer therapy: is there any light at the end of the tunnel? Acta Myol 24: 128-133.
5. Negroni E, Butler-Browne GS, Mouly V, (2006) Myogenic stem cells: regeneration and cell therapy in human skeletal muscle. Pathol Biol (Paris) 54: 100-108.
6. Shi X, Garry DJ, (2006) Muscle stem cells in development, regeneration, and disease. Genes Dev 20: 1692-1708.
7. Muir LA, Chamberlain JS, (2009) Emerging strategies for cell and gene therapy of the muscular dystrophies. Expert Rev Mol Med 11: e18.
8. Chamberlain JS, (2002) Gene therapy of muscular dystrophy. Hum Mol Genet 11: 2355-2362.
9. Kapsa R, Kornberg AJ, Byrne E, (2003) Novel therapies for Duchenne muscular dystrophy. Lancet Neurol 2: 299-310.
10. Demarquoy J, Rigault C, Le Borgne F (2010) "L-carnitine". Handbook of Analysis of Active Compounds in Functional Foods (CRCPress- Francis & Taylor Group USA): In press.
11. Rigault C, Le Borgne F, Demarquoy J, (2006) Genomic structure, alternative maturation and tissue expression of the human BBOX1 gene. Biochim Biophys Acta 1761: 1469-1481.
12. Berthillier G, Eichenberger D, Carrier HN, Guibaud P, Got R, (1982) Carnitine metabolism in early stages of Duchenne muscular dystrophy. Clin Chim Acta 122: 369-375.
13. Camina F, Novo-Rodriguez MI, Rodriguez-Segade S, Castro-Gago M, (1995) Purine and carnitine metabolism in muscle of patients with Duchenne muscular dystrophy. Clin Chim Acta 243: 151-164.
14. Sharma U, Atri S, Sharma MC, Sarkar C, Jagannathan NR, (2003) Skeletal muscle metabolism in Duchenne muscular dystrophy (DMD): an in-vitro proton NMR spectroscopy study. Magn Reson Imaging 21: 145-153.
15. Piperi C, Papapanagiotou A, Kalofoutis C, Zisaki K, Michalaki V, et al. (2004) Altered long chain fatty acids composition in Duchenne muscular dystrophy erythrocytes. In Vivo 18: 799-802.
16. Carroll JE, Villadiego A, Brooke MH, (1983) Increased long chain acyl CoA in Duchenne muscular dystrophy. Neurology 33: 1507-1510.
17. Kawashima H, Watanabe K, Morishima Y, Ioi H, Kashiwagi Y, et al. (2012) High concentration of middle chain fatty acid in a case of Duchenne muscular dystrophy with severe mental retardation. Pediatr Int 54: 137-140.
18. Benabdellah F, Yu H, Brunelle A, Laprevote O, De La Porte S, (2009) MALDI reveals membrane lipid profile reversion in MDX mice. Neurobiol Dis 36: 252-258.
19. Touboul D, Piednoel H, Voisin V, De La Porte S, Brunelle A, et al. (2004) Changes of phospholipid composition within the dystrophic muscle by matrix-assisted laser desorption/ionization mass spectrometry and mass spectrometry imaging. Eur J Mass Spectrom (Chichester, Eng) 10: 657-664.
20. Even PC, Decrouy A, Chinet A, (1994) Defective regulation of energy metabolism in mdx-mouse skeletal muscles. Biochem J 304 (Pt 2): 649-654.
21. Tuazon MA, Henderson GC, (2012) Fatty acid profile of skeletal muscle phospholipid is altered in mdx mice and is predictive of disease markers. Metabolism 61: 801-811.
22. Khairallah M, Khairallah R, Young ME, Dyck JR, Petrof BJ, et al. (2007) Metabolic and signaling alterations in dystrophin-deficient hearts precede overt cardiomyopathy. J Mol Cell Cardiol 43: 119-129.
23. Rowland LP, (1980) Biochemistry of muscle membranes in Duchenne muscular dystrophy. Muscle Nerve 3: 3-20.
24. Spector AA, Yorek MA, (1985) Membrane lipid composition and cellular function. J Lipid Res 26: 1015-1035.
25. Stubbs CD, Smith AD, (1984) The modification of mammalian membrane polyunsaturated fatty acid composition in relation to membrane fluidity and function. Biochim Biophys Acta 779: 89-137.
26. Chabanel A, Spiro A, Schachter D, Chien S, (1986) Some biophysical properties of the erythrocyte membrane in Duchenne muscular dystrophy. J Neurol Sci 76: 131-142.
27. Hubner C, Kohlschutter A, Gartner J, (1987) Membrane fluidity of nonmuscle cells in Duchenne muscular dystrophy: effect on lymphocyte membranes of incubation in patient and control sera. Pediatr Res 22: 488-492.
28. Demarquoy J, Georges B, Rigault C, Royer M, Clairet A, et al. (2004) Radioisotopic determination of-carnitine content in foods commonly eaten in Western countries. Food Chemistry 86: 137-142.
29. Georges B, Le Borgne F, Galland S, Isoir M, Ecosse D, et al. (2000) Carnitine transport into muscular cells. Inhibition of transport and cell growth by mildronate. Biochem Pharmacol 59: 1357-1363.
30. Le Borgne F, Ben Mohamed A, Logerot M, Garnier E, Demarquoy J, (2011) Changes in carnitine octanoyltransferase activity induce alteration in fatty acid metabolism. Biochem Biophys Res Commun 409: 699-704.
31. Folch J, Lees M, Sloane Stanley GH, (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226: 497-509.
32. Pfaffl MW, Horgan GW, Dempfle L, (2002) Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30: e36.
33. Tamai I (2012) Pharmacological and pathophysiological roles of carnitine/organic cation transporters (OCTNs: SLC22A4, SLC22A5 and Slc22a21). Biopharm Drug Dispos.
34. Shumate JB, Carroll JE, Brooke MH, Choksi RM, (1982) Palmitate oxidation in human muscle: comparison to CPT and carnitine. Muscle Nerve 5: 226-231.
35. Imbert N, Cognard C, Duport G, Guillou C, Raymond G, (1995) Abnormal calcium homeostasis in Duchenne muscular dystrophy myotubes contracting in vitro. Cell Calcium 18: 177-186.
36. Cardenas C, Juretic N, Bevilacqua JA, Garcia IE, Figueroa R, et al. (2010) Abnormal distribution of inositol 1,4,5-trisphosphate receptors in human muscle can be related to altered calcium signals and gene expression in Duchenne dystrophy-derived cells. FASEB J 24: 3210-3221.
37. Spiekerkoetter U, Wood PA, (2010) Mitochondrial fatty acid oxidation disorders: pathophysiological studies in mouse models. J Inherit Metab Dis 33: 539-546.
38. Nishio H, Wada H, Matsuo T, Horikawa H, Takahashi K, et al. (1990) Glucose, free fatty acid and ketone body metabolism in Duchenne muscular dystrophy. Brain Dev 12: 390-402.
39. Broad EM, Maughan RJ, Galloway SD, (2011) Effects of exercise intensity and altered substrate availability on cardiovascular and metabolic responses to exercise after oral carnitine supplementation in athletes. Int J Sport Nutr Exerc Metab 21: 385-397.
40. Reuter SE, Evans AM, (2012) Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspects. Clin Pharmacokinet 51: 553-572.
41. Fischbeck KH, Bonilla E, Schotland DL, (1983) Freeze-fracture analysis of plasma membrane cholesterol in Duchenne muscle. Ann Neurol 13: 532-535.
42. Tahallah N, Brunelle A, De La Porte S, Laprevote O, (2008) Lipid mapping in human dystrophic muscle by cluster-time-of-flight secondary ion mass spectrometry imaging. J Lipid Res 49: 438-454.
43. Bastiaanse EM, Hold KM, Van der Laarse A, (1997) The effect of membrane cholesterol content on ion transport processes in plasma membranes. Cardiovasc Res 33: 272-283.
44. Lamhonwah AM, Tein I, (2006) Novel localization of OCTN1, an organic cation/carnitine transporter, to mammalian mitochondria. Biochem Biophys Res Commun 345: 1315-1325.
45. Guevel L, Lavoie JR, Perez-Iratxeta C, Rouger K, Dubreil L, et al. (2011) Quantitative proteomic analysis of dystrophic dog muscle. J Proteome Res 10: 2465-2478.
46. Poulos A, (1995) Very long chain fatty acids in higher animals-a review. Lipids 30: 1-14.
47. Beney L, Gervais P, (2001) Influence of the fluidity of the membrane on the response of microorganisms to environmental stresses. Applied Microbiology and Biotechnology 57: 34-42.
48. Koenig M, Monaco AP, Kunkel LM, (1988) The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell 53: 219-228.
49. Ervasti JM, Ohlendieck K, Kahl SD, Gaver MG, Campbell KP, (1990) Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature 345: 315-319.
50. Mora MP, Tourne-Peteilh C, Charveron M, Fabre B, Milon A, et al. (1999) Optimisation of plant sterols incorporation in human keratinocyte plasma membrane and modulation of membrane fluidity. Chemistry and Physics of Lipids 101: 255-265.
51. Sharif-Naeini R, Folgering JH, Bichet D, Duprat F, Lauritzen I, et al. (2009) Polycystin-1 and-2 dosage regulates pressure sensing. Cell 139: 587-596.
52. Patel A, Sharif-Naeini R, Folgering JR, Bichet D, Duprat F, et al. (2010) Canonical TRP channels and mechanotransduction: from physiology to disease states. Pflugers Archiv- European Journal of Physiology 460: 571-581.
53. Parthasarathy R, Yu CH, Groves JT, (2006) Curvature-modulated phase separation in lipid bilayer membranes. Langmuir 22: 5095-5099.
54. Lee DC, Chapman D, (1987) The effects of temperature on biological membranes and their models. Symposia of the Society for Experimental Biology 41: 35-52.